Lisa Swanson, MD, FAAD, Talks About Fall Clinical

Transcript

Hi everybody, my name is Lisa Swanson, MD, FAAD. I'm a pediatric dermatologist in Boise, Idaho. I work in a practice called Ada West dermatology and I'm affiliated with St. Luke's Children's Hospital, right here in potato land, Boise, Idaho. I'm super excited for my talk later this week at Fall Clinicall: it's going to be a whirlwind, folks. I'm telling you, I've got 15 minutes to tell everybody about what's new and hot in pediatric dermatology and it's really hard to squeeze it all in because peds derm, this is where it's at. Pediatric dermatology is pretty darn cool. I'm going to tell you about what's new and hot in atopic dermatitis, which is a lot. We have some wonderful new tools to help us with pediatric and teenage patients. Dealing with atopic dermatitis, I'm going to give you some helpful tips and tricks, about treatments and just the impact of disease burden of disease, things that you may not otherwise be aware of. We're going to talk about pediatric psoriasis and why it's so important to effectively treat pediatric psoriasis and our younger patients. I'm going to give you some really good tips on treating warts to make your life and your patients life easier. We're going to talk about advances in things like alopecia areata; we're going to talk about JAK inhibitors, we're going to talk about the global age of dermatology, because it's really exciting times for us these days, we have more tools in our toolbox than ever before, to help our patients live better lives.

Now, I hope all of you guys are able to attend this session. But for those of you that can't, I'll give you a few little tidbits, a little teaser. So for atopic dermatitis, what's new and hot for atopic dermatitis for our pediatric patients, we've got the approval of Dupixent, down to the age of 6 months. I'm going to give people in the audience some helpful tips on how to administer these shots to our youngest patients. And I'm going to talk about live vaccines. How do we manage that in some of our youngest patients who might be receiving live vaccinations.

I can tell you that in these studies on Dupixent, in the youngest population, what they did was they would give the Dupixent, then wait 12 weeks, then they give the live vaccinations, then wait 4 weeks and restart the Dupixent. So that's a reasonable method, it seems to me to follow.

In the world of pediatric psoriasis, we've got so many options. Now we've got 4 FDA approved biologics to treat our pediatric patients, 2 of which are IL-17 inhibitors, secukinumab and ixekizumab. And one of the biggest hot topics with these agents is potential risk for inflammatory bowel disease. And so I've come up with 4 good screening questions and 3 good screening labs to tell your patients to try to educate them about this risk, and make sure that you're mitigating their risk in whatever way possible. So the 4 screening questions: Number one, family history of Crohn's disease because it increases the child's risk of having Crohn's. Number 2, growth issues if they're having trouble keeping up with the growth curve. Number 3, nocturnal diarrhea or nocturnal bowel movements can be a sign of Crohn's in kids. And number 4, issues like anal fissures pain, going to the bathroom and blood on the toilet paper, that sort of thing. The 3 screening labs include a CBC to evaluate for anemia, a CRP to as an indicator of inflammation and a fecal calprotectin level, which is a test that's done on a stool sample. That can be a good indicator if a patient has some underlying inflammatory bowel disease.

When it comes to treating warts in kids, which is a common ailment, my favorite treatment for warts in kids is a prescription compound available through a mail order pharmacy, and it's called Wart Peel. So during the talk, I'm going to give people a lot of helpful tips about how to use Wart Peel and how well it works and show some impressive before and after pictures as well.

So I'm so looking forward to seeing those of you that can make it anybody who can't hopefully you got a little bit from this teaser. Thank you so much.